© Drug Hunter Inc. 2018-2023
Home > “compound 25”
IRE1_ kinase-binding endonuclease inhibitor
unfolded prot. response disruption for MM
from kinase library screen and SBDD
ACS Med. Chem. Lett, Oct. 16, 2020
Genentech, So. San Francisco, CA / Paraza, QC
“compound 25” (Genentech IRE1 alpha kinase-binding endonuclease inhibitor)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year